| |
|
| |
| THE GENERAL ASSEMBLY OF PENNSYLVANIA |
| |
| HOUSE RESOLUTION |
|
| |
| |
| INTRODUCED BY TOOHIL, BAKER, BRADFORD, BRENNAN, CALTAGIRONE, CLYMER, D. COSTA, CREIGHTON, DiGIROLAMO, DONATUCCI, EVERETT, FLECK, FRANKEL, GEIST, GEORGE, GILLEN, GILLESPIE, GINGRICH, GOODMAN, GRELL, GROVE, HACKETT, HARHART, HEFFLEY, HELM, HENNESSEY, HESS, HICKERNELL, KILLION, KIRKLAND, KNOWLES, KULA, MAHONEY, MAJOR, MANN, MARSICO, MILLARD, MOUL, MURT, MUSTIO, MYERS, O'NEILL, READSHAW, ROCK, ROSS, SANTARSIERO, SCAVELLO, SCHRODER, SONNEY, SWANGER, VULAKOVICH AND YOUNGBLOOD, APRIL 18, 2012 |
| |
| |
| INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35, APRIL 18, 2012 |
| |
| |
| |
| A RESOLUTION |
| |
1 | Designating the month of June 2012 as "Cockayne Syndrome |
2 | Awareness Month" in Pennsylvania and commending the work of |
3 | the Share and Care Cockayne Syndrome Network for raising |
4 | awareness of this disease. |
5 | WHEREAS, Cockayne Syndrome, or CS, is a rare genetic disorder |
6 | affecting a small number of children worldwide, but its impact |
7 | on involved families is significant emotionally and |
8 | economically; and |
9 | WHEREAS, Edward Alfred Cockayne (1880-1956), after whom this |
10 | disease is named, was a London physician who concentrated |
11 | particularly on hereditary diseases of children; and |
12 | WHEREAS, CS is inherited in an autosomal recessive pattern; |
13 | therefore, in order for a child to be affected by CS, he or she |
14 | must inherit a mutation in the same CS gene from both parents; |
15 | and |
|
1 | WHEREAS, While parents, who are carriers of a single CS gene |
2 | mutation, remain healthy after the birth of a child with CS, |
3 | they have a one in four, or 25%, chance of having a second or |
4 | successive child with CS; and |
5 | WHEREAS, The symptoms of CS vary significantly, especially |
6 | with regard to the age of onset and rate of progression, and |
7 | include social, jovial personalities; sunburning easily; |
8 | progeria (premature aging); shortened life span; microcephaly; |
9 | neurodevelopment delay; short stature (height lower than the 5th |
10 | percentile for others in the age group); contractures; unsteady |
11 | gait; spasticity; rounded back; deep-set eyes and a small, |
12 | slender, straight nose; dental caries (cavities); retinopathy |
13 | and cataracts; hearing loss; poor circulation (cold hands and |
14 | feet); low body temperature; feeding problems; sleeping with |
15 | eyes open; tremors; white matter abnormalities; basal ganglia |
16 | calcifications; liver abnormalities; elevated liver enzymes; |
17 | hypertension; and severe itchiness; and |
18 | WHEREAS, The resulting spectrum of severity can be loosely |
19 | divided into three "types" of CS: |
20 | (1) CS Type I is characterized by normal prenatal growth |
21 | with the onset of growth and developmental abnormalities |
22 | around one year of age. The typical lifespan is 10 to 20 |
23 | years of age. |
24 | (2) CS Type II is characterized by growth failure and |
25 | other abnormalities at birth, with little or no postnatal |
26 | neurological development. The typical lifespan is up to seven |
27 | years of age. |
28 | (3) CS Type III is characterized by a later onset, |
29 | lesser symptoms and a slower rate of progression. The |
30 | expected lifespan is unclear, but can extend to 40 or 50 |
|
1 | years of age; |
2 | and |
3 | WHEREAS, Some individuals have combined features of CS and |
4 | Xeroderma Pigmentosum, which is characterized by a wide range of |
5 | skin changes from mild freckling to skin cancer on areas exposed |
6 | to sunlight; and |
7 | WHEREAS, No specific treatment currently exists for CS, and |
8 | patients are treated according to the symptoms they have, with |
9 | physical, occupational, speech, vision and hearing therapies |
10 | being beneficial; and |
11 | WHEREAS, It is important to those affected by CS to raise |
12 | awareness of this disease so that they find social and medical |
13 | support easily, and the Share and Care Cockayne Syndrome Network |
14 | provides information and support for those afflicted; therefore |
15 | be it |
16 | RESOLVED, That the House of Representatives designate the |
17 | month of June 2012 as "Cockayne Syndrome Awareness Month" in |
18 | Pennsylvania and commend the work of the Share and Care Cockayne |
19 | Syndrome Network for raising awareness of this disease. |
|